Biomedical Engineering Reference
In-Depth Information
13. Lau, T. K., Lo, K. W., Chan, L. Y. S., Leung, T. Y., and Lo, Y. M. D. (2000) Cell-
free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-
maternal hemorrhage in patients undergoing external cephalic version near term.
Am
J. Obstet. Gynecol.
183,
712-716.
14. Sekizawa, A., Jimbo, M., Saito, H., et al. (2002) Increased cell-free fetal DNA in
plasma of two women with invasive placenta.
Clin. Chem.
48,
353-354.
15. Jimbo, M., Sekizawa, A., Sugito, Y., et al. (2003) Placenta increta: Postpartum
monitoring of plasma cell-free fetal DNA.
Clin. Chem.
49,
1540-1541.
16. Sugito, Y., Sekizawa, A., Farina, A., et al. (2003) Relationship between severity
of hyperemesis gravidarum and fetal DNA concentration in maternal plasma.
Clin.
Chem.
49,
1667-1669.
17. Zhong, X. Y., Holzgreve, W., Li, J. C., Aydinli, K., and Hahn, S. (2000) High
levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of
a pregnant woman with idiopathic polyhydramnios: case report.
Prenat. Diagn.
20,
838-841.
18. Lo, Y. M. D., Hjelm, N. M., Fidler, C., et al. (1998) Prenatal diagnosis of fetal
RhD status by molecular analysis of maternal plasma.
N. Engl. J. Med.
339,
1734-1738.
19. Hromadnikova, I., Vechetova, L., Vesela, K., Benesova, B., Doucha, J., and Vik,
R. (2005) Non-invasive fetal RHD and RHCE genotyping using real-time PCR
testing of maternal plasma in RhD-negative pregnancies.
J. Histochem. Cytochem.
53,
301-305.
20. Chiu, R. W. K., Lau, T. K., Leung, T. N., et al. (2002) Prenatal exclusion of beta
thalassaemia major by examination of maternal plasma.
Lancet
360,
998-1000.
21. Li, Y., Di Naro, E., Vitucci, A., Zimmermann, B., Holzgreve, W., and Hahn, S.
(2005) Detection of paternally inherited fetal point mutations for beta-thalassemia
using size-fractionated cell-free DNA in maternal plasma.
JAMA
293,
843-849.
22. Chiu, R. W. K., Lau, T. K., Cheung, P. T., Gong, Z. Q., Leung, T. N., and Lo, Y.
M. D. (2002) Noninvasive prenatal exclusion of congenital adrenal hyperplasia
by maternal plasma analysis: a feasibility study.
Clin. Chem.
48,
778-780.
23. Li, Y., Holzgreve, W., Page-Christiaens, G. C., Gille, J. J., and Hahn, S. (2004)
Improved prenatal detection of a fetal point mutation for achondroplasia by the
use of size-fractionated circulatory DNA in maternal plasma.
Prenat. Diagn.
24,
896-898.
24. Chiu, R. W. K. and Lo, Y. M. D. (2004) The biology and diagnostic applications
of fetal DNA and RNA in maternal plasma.
Curr. Top.
Dev. Biol.
61,
81-111.
25. Chiu, R. W. K., Poon, L. L. M., Lau, T. K., Leung, T. N., Wong, E. M. C., and Lo,
Y. M. D. (2001) Effects of blood-processing protocols on fetal and total DNA
quantification in maternal plasma.
Clin. Chem.
47,
1607-1613.
26. Lee, T., LeShane, E. S., Messerlian, G. M., et al. (2002) Down syndrome and
cell-free fetal DNA in archived maternal serum.
Am. J. Obstet. Gynecol.
187,
1217-1221.
27. Lui, Y. Y. N., Chik, K. W., Chiu, R. W. K., Ho, C. Y., Lam, C. W., and Lo, Y. M.
D. (2002) Predominant hematopoietic origin of cell-free DNA in plasma and
